AzTrials
AzTrials

PretermNCT06232811

Mother-to-infant Bonding and Prematurity Are Associated With Sensory Processing at 12 Months of Age

An observational study of Preterm and Sensory Disorder, run by Gazi University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Establishing a strong bond between mother and infant is crucial for fostering healthy relationships in the future. This research sought to investigate the correlation between mother-to-infant bonding and sensory processing, as well as the connection between prematurity and sensory processing in 12-month-old infants. Read more about this study

Who is it for?
Ages 12 to 12 monthsHealthy volunteers can take part
Conditions the study is for
Preterm, Sensory Disorder, Attachment Disorder
What is being tested?
Assessment
How many people
42 participants
Where
1 siteTurkey (Türkiye)
Study dates
21 Apr 2023to 15 Jan 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 to 12 months
  • All sexes
  • Healthy volunteers accepted
  • Child

Study population: Preterm and term children aged 12 months

Who may be able to join

  • preterm children with a gestational age <34 weeks Term children with a gestational age between 37 and 41 weeks

Who cannot join

  • infants with chromosomal defects, metabolic or neuromuscular disease,
  • hydrocephalus, cerebral palsy, congenital heart disease,

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Erzurum Technical University

    Erzurum

Other trials in Turkey (Türkiye)

About this study

Establishing a strong bond between mother and infant is crucial for fostering healthy relationships in the future. This research sought to investigate the correlation between mother-to-infant bonding and sensory processing, as well as the connection between prematurity and sensory processing in 12-month-old infants.

Read the detailed description

At the age of four months, mothers will utilize the Mother-Infant Attachment Scale (MIBS) to evaluate the bonding between themselves and their infants. Subsequently, at 12 months old, the sensory processing abilities of the infants will be assessed using the Test of Sensory Functions in Infants (TSFI). The study will encompass both preterm and term-born children.

Being tested
Assessment
Medical subject headings
Premature Birth, Sensation Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • AssessmentBehavioural

    Sensory processing skills of children in the preterm and term groups will be evaluated. Additionally, the attachment between mother and baby will be evaluated.

Study groups in NCT06232811
Study groupRoleWhat they receive
Pretermpreterm infants with gestational age <34 weeks
Receives: Behavioral: Assessment
Termterm infants with gestational age >37 weeks
Receives: Behavioral: Assessment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Mother-to-Infant Bonding Scale

    The Mother-to-Infant Bonding Scale is a tool designed for evaluating mother-infant bonding. Comprising 10 items on a 4-point scale, this scale yields a total score ranging from 0 to 30. Higher scores on the scale are indicative of poorer mother-to-infant bonding.

    Measured: 15 minutes

  2. Test of Sensory Functions in Infants

    The test consists of 24 items divided into five subtests: sensory processing and reactivity. subtests include: deep pressure, adaptive motor functions, visual-tactile integration, ocular-motor control, and vestibular stimulation. By observing the baby's response, items are scored from negative to normal according to the criteria provided; Items are given 0, 1 or 2 points depending on the baby's reaction.

    Measured: 30 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Jan 2024
  2. Study start21 Apr 2023
  3. Primary completion21 Nov 2023
  4. Study completion15 Jan 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
42 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06232811
Sponsor's protocol ID
E-77082166-604.01.02-639350
Status last verified
Jan 2024
First submitted
22 Jan 2024
Last updated
31 Jan 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Preterm and Sensory Disorder, run by Gazi University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 31 Jan 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Mother-to-Infant Bonding Scale (time frame: 15 minutes). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Jan 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in